Article PDF
Avoid common mistakes on your manuscript.
References
Meduri GU, Headley AS, Golden E, et al. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998; 280:159–65.
Meduri GU, Chrousos GP. Effectiveness of prolonged glucocorticoid treatment in acute respiratory distress syndrome: the right drug, the right way? Crit Care Med2006; 34:236–8.
Meduri GU, Tolley E A, Chrousos GP, Stentz F.Prolonged methylprednisolone treatment suppresses systemic inflammation in patients with unresolving acute respiratory distress syndrome: evidence for inadequate endogenous glucocorticoid secretion and inflammation-induced immune cell resistance to glucocorticoids. Am J Respir Crit Care Med 2002; 165:983–91.
Meduri GU, Muthiah MP, Carratu P, Eltorky M,hrousos GP. Nuclear factor ?B and glucocorticoid receptor ?-mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome. Evidence for inflammation-induced target tissue resistance to glucocorticoids. Neuroimmunomodulation 2005; 12:321–38.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ewanchuk, M.A., Jacka, M.J. Steroids in fibroproliferative acute respiratory distress syndrome: approach with care. Can J Anesth 54, 765–766 (2007). https://doi.org/10.1007/BF03026873
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03026873